Meatly Unveils Protein-Free Medium
7th May 2024
("Agronomics" or the "Company")
Portfolio Company Meatly Unveils Protein-Free Medium
Agronomics (LSE: ANIC), a leading listed company focused on the field of cellular agriculture, is pleased to announce that portfolio company Good Dog Food Limited trading as Meatly ("Meatly") has achieved a significant milestone in developing a protein-free culture medium costing only one pound per litre.
Culture medium is an essential element in the production of cultivated meat, providing cells with the nutrients required for in vitro viability and proliferation. Although animal cell culture is routinely performed in academic labs, creating the amount of biomass required for commercial scale and price points demands significant cost reductions and innovations for the replacement of certain medium components such as fetal bovine serum and albumin. Medium costs account for a significant portion of the costs of producing cultivated meat and reducing them is a well-known hurdle the industry faces as it looks to scale up and achieve price parity with conventional meat products.
Agronomics' team has observed that medium prices vary substantially between companies and in some cases are still at levels exceeding hundreds of pounds per litre, making industrial production economically unviable. However, Meatly's new medium contains no serum, animal-derived components, steroids, hormones, growth factors, or antibiotics, and is used in their suspension culture bioreactors without micro-carriers. The absence of these expensive proteins, such as transferrin and insulin, as well as growth factors and micro-carriers, means the production of Meatly's protein-free culture medium at an industrial scale is economically viable - at the price of one pound a litre. Meatly believes further cost reduction will be possible when higher volumes of the medium are purchased.
Helder Cruz, Co-founder and Chief Scientific Officer at Meatly, said:
"Our protein-free culture medium represents a critical milestone for us and the wider cultivated meat industry. By setting this new benchmark, we are driving the cost of production down significantly, which is something the industry has been grappling with for years and is a huge step forward in scaling our technology and making our products available to pet owners at an affordable price and on a commercial scale."
Jim Mellon, Founder of Agronomics, an investor in Meatly, added:
"Meatly's creation of the very first protein-free medium establishes the company as a true technological leader within its field. Medium accounts for the majority of the costs involved in the production of cultivated meat and Meatly has single-handedly slashed those costs a hundredfold or more. This is a huge step forward in bringing the cost of cultivated meat to price-parity with conventional meat and, ultimately, toward the mass adoption of cultivated products. The company expects to shortly receive regulatory approval, and I am excited to feed their delicious product to my dogs."
Looking ahead, Meatly is gearing up for the release of its product in the coming months, backed by investors such as Pets at Home and Agronomics. In March, Meatly announced the production of the world's first cans of cultivated pet food, which it aims to sell in the UK this year, becoming the first company to sell cultivated meat in Europe.
With achievements realised on a budget of £3.6 million over a period of approximately 18 months, the company's trajectory is a hugely positive indication for the industry at large as it looks to commercialise and realise the ethical and environmental benefits cultivated meat can provide.
About Meatly
Meatly (previously known as Good Dog Food) was founded in 2022 by CEO Owen Ensor and CSO Dr Helder Cruz with backing from investor Agronomics. The company produces ethical and sustainable cultivated meat products without compromising on essential nutritional benefits. Their current focus is on the pet food market.
About Agronomics
Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture including precision fermentation and cultivated meat. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.
For further information please contact:
|
Agronomics Limited |
Beaumont Cornish Limited |
Canaccord Genuity Limited |
Cavendish Capital Markets Limited |
Peterhouse Capital Limited |
SEC Newgate |
|
The Company |
Nomad |
Joint Broker |
Joint Broker |
Joint Broker |
Public Relations |
|
Jim Mellon Denham Eke |
Roland Cornish James Biddle |
Andrew Potts Harry Pardoe Alex Aylen |
Giles Balleny Michael Johnson Charlie Combe |
Lucy Williams Charles Goodfellow |
Bob Huxford |
|
+44 (0) 1624 639396 info@agronomics.im |
+44 (0) 207 628 3396 |
+44 (0) 207 523 8000 |
+44 (0) 207 397 8900 |
+44 (0) 207 469 0936 |
agronomics@secnewgate.co.uk |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 4 hours ago Savannah Energy
- 5 hours ago Buccaneer Energy PLC
- 5 hours ago Savannah Energy
- 5 hours ago Carclo
- 6 hours ago Schroder Japan Growth Fund